Researchers track future fertility in young sickle cell patients on common drug

NCT ID NCT07116772

Recruiting now Knowledge-focused Sponsor: Children's Hospital Medical Center, Cincinnati Source: ClinicalTrials.gov ↗

Summary

This long-term study follows 250 adolescents and young adults with sickle cell anemia to understand how the medication hydroxyurea affects their growth, puberty development, and future ability to have children. Researchers will monitor participants over time through regular check-ups, blood tests, and fertility assessments. The goal is to gather important information about reproductive health outcomes for people living with this chronic blood disorder.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL ANEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Buganda Medical Centre
RECRUITING

Mwanza, Tanzania

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Caribbean Institute for Health Research, University of West Indies
RECRUITING

Kingston, Jamaica

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centro de Obstetricia y Ginecologia
RECRUITING

Santo Domingo, Dominican Republic

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SICKLE CELL ANEMIA